期刊文献+

难治及复发重型再生障碍性贫血研究现状 被引量:2

原文传递
导出
摘要 重型再生障碍性贫血(SAA)是免疫介导的,以骨髓造血干细胞(HSC)及造血微环境损伤、骨髓脂肪化和外周血全血细胞减少为特征的造血功能衰竭综合征。临床上表现为严重的感染、出血和贫血。目前,免疫抑制治疗(IST)与同胞供者骨髓移植(BMT)并列为SAA标准疗法。临床研究证实抗淋巴细胞球蛋白(ALG)/抗胸腺细胞球蛋白(ATG)联合环孢素(CsA)的强化IST有效率可达70%~80%。尽管如此,仍有一部分患者属IST难治或IST后复发,特别是前者,预后较差。我们对IST难治和复发SAA的研究现状作一综述。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第2期137-140,共4页 Chinese Journal of Hematology
  • 相关文献

参考文献27

  • 1Marsh JC.Management of acquired aplastic anaemia.Blood Rev,2005,19:143-151.
  • 2Scheinberg P,Nunez O,Young NS.Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.Br J Haematol,2006,133:622-627.
  • 3Rosenfeld S,Follmann D,Nunez O,et al.Antithymocyte globulin and cyclosporine for severe aplastic anaemia:association between hematologic response and long-term outcome.JAMA,2003,289:1130-1135.
  • 4Frickhofen N,Heimpel H,Kaltwasser JP,et al.Antithymocyte globulin with or without cyclosporin A:11 -year follow-up of a randomized trial comparing treatments of aplastic anemia.Blood,2003,101:1236-1242.
  • 5Sloand E,Kim S,Maciejewski JP,et al.Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia.Blood,2002,100:1185-1191.
  • 6Maciejewski JP,Follmann D,Nakamura R,et al.Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.Blood,2001,98:3513-3519.
  • 7Sugimori C,Chuhjo T,Feng X,et al.Minor population of CD55-CD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.Blood,2006,107:1308-1314.
  • 8Bacigalupo A,Bruno B,Saracco P,et al.Antilymphocyte globulin,cyclosporine,prednisolone,and granulocyte colony-stimulating factor for severe aplastic anemia:an update of the GITMO/EBMT study on100 patients.Blood,2000,95:1931-1934.
  • 9Ahn MJ,Choi JH,Lee YY,et al.Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation:multicenter trial.Int J Hematol,2003,78:133-138.
  • 10Maciejewski JP,Risitano AM.Aplastic anemia:management of a adult patient.ASH Edu Book,2005.110-117.

同被引文献9

  • 1张宏丽(综述),郑以州(审校).重复应用ALG/ATG治疗重型再生障碍性贫血的研究现状[J].国际输血及血液学杂志,2007,30(1):58-61. 被引量:2
  • 2Zheng Y, Liu Y, Chu Y. Immunosuppressive therapy for acquired severe aplastic anemia (SAA) : a prospective comparason of four different regimens. Exp Hematol, 2006; 34:826-831.
  • 3Tichelli A, Passweg J, Nissen C, et al. Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. Br J Haematol, 1998, 100:393-400.
  • 4di Bona E, Rodeghiero F, Bruno B, et al. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anemia patients unresponsive to a first course of intensive Haematol, 1999,107:330-334.
  • 5Rosenfeld S, Follmann D, Nunez O, et al. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA, 2003,289:1130- 1135.
  • 6Frickhofen N, Heimpel H, Kaltwasser JP, et al. Antithymocyte globulin with or without cyclosporin A : 11 -year follow-up of a randomized trim comparing treatments of aplastic anemia. Blood, 2003, 101: 1236-1242.
  • 7Zheng Y, Liu Y, Chu Y. Immunosuppressive therapy for ac- quired severe aplastie anemia(SAA) :a prospective comparason of four different regimens [J]. Exp Hematol, 2006, 34: 826- 831.
  • 8郑以州,储榆林,邵宗鸿,张益枝,陈桂彬.抗淋巴细胞球蛋白联合环孢霉素A治疗重型再生障碍性贫血的临床研究[J].中华血液学杂志,1999,20(4):175-177. 被引量:23
  • 9肖海燕,刘驰,郑春梅,刘锋.二次抗淋巴细胞球蛋白/抗胸腺细胞球蛋白治疗重型再生障碍性贫血4例临床分析[J].临床血液学杂志,2011,24(3):303-306. 被引量:3

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部